Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families (Q24796660)

2 July 2017

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families (English)

1 reference

2 July 2017

1 reference

1 reference

6

1 reference

2 July 2017

4

Kristiina Aittomäki

0 references

Carl Blomqvist

series ordinal

5

object named as

Carl Blomqvist

1 reference

2 July 2017

2

Päivi Heikkilä

1 reference

2 July 2017

1

Hannaleena Eerola

1 reference

2 July 2017

3

Anitta Tamminen

1 reference

PubMed ID

15642173

2 July 2017

language of work or name

English

0 references

publication date

19 November 2004

1 reference

2 July 2017

Breast Cancer Research

1 reference

2 July 2017

7

1 reference

2 July 2017

1

1 reference

2 July 2017

R93-100

1 reference

Evidence of founder mutations in Finnish BRCA1 and BRCA2 families

2 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064101

Repeated observation of breast tumor subtypes in independent gene expression data sets

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064101

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064101

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064101

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064101

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064101

Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064101

Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064101

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064101

A low proportion of BRCA2 mutations in Finnish breast cancer families.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064101

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064101

Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.

30 May 2018

1 reference

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

21 January 2018

1 reference

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

21 January 2018

1 reference

Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study Group

21 January 2018

1 reference

Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre- and postmenopausal women

21 January 2018

1 reference

Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups

21 January 2018

1 reference

Gene-Expression Profiles in Hereditary Breast Cancer

21 January 2018

1 reference

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes

21 January 2018

1 reference

Familial breast cancer in southern Finland

21 January 2018

1 reference

Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland

21 January 2018

1 reference

BRCA1and Medullary Breast Cancer

21 January 2018

1 reference

Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064101

Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064101

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

28 November 2018

1 reference

12 December 2020

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer

1 reference

12 December 2020

Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women

1 reference

12 December 2020

Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer

1 reference

12 December 2020

Tumour biological features of BRCA1-induced breast and ovarian cancer

1 reference

12 December 2020

A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center

1 reference

12 December 2020

The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2

1 reference

12 December 2020

Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer

1 reference

12 December 2020

Comparative study of clinical, pathological and biological characteristics of symptomatic versus asymptomatic breast cancers

1 reference

12 December 2020

The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study

1 reference

12 December 2020

The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations

1 reference

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1186/BCR953

1 reference

PubMed ID

15642173

Dimensions Publication ID

2 July 2017

1021729382

0 references

OpenCitations bibliographic resource ID

3971656

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

PubMed ID

15642173